-
Budget Impact of an Organized Screening Program for Chronic Kidney Disease in High-Risk Populations in France
Sep 9, 2025, 16:22 PM -
Implementing Simultaneous Maximum Acceptable Risk Thresholds (SMARTs) in Discrete Choice Experiments (DCE): A Feasible Approach to Quantify Tolerance for Multiple Risks
Sep 9, 2025, 16:22 PM -
Balancing Power and Interpretation: Responder Analysis vs. Mean Differences for PRO Endpoints in Oncology Clinical Trials
Sep 9, 2025, 16:22 PM -
Quantifying the Therapeutic Benefit of External Beam Radiotherapy in Uterine Serous Carcinoma: A Real-World Study
Sep 9, 2025, 16:22 PM -
Evolution of Acceptance of Evidence and PMA Outcomes by HTA Authorities for ATMPs in the EU4 and the UK 2017-2025
Sep 9, 2025, 16:22 PM -
Advancing Target Trial Emulation With Synthetic Data: The Target Trial Optimization Framework
Sep 9, 2025, 16:22 PM -
Impact of Individualized Neoantigen Therapies on Health, Productivity, and Health System Capacity Outcomes in Resected Melanoma in Belgium
Sep 9, 2025, 16:22 PM -
Will Patient Input Shape EU-Level Health Technology Assessments? HTA Representative Perspectives on the EU HTA Regulation
Sep 9, 2025, 16:22 PM -
Implications of Recent US Policy Changes on Evidence Generation Requirements for Enabling Access to Medicines and Vaccines in Low- and Middle-Income Countries
Sep 9, 2025, 16:22 PM -
Zoom Out: Simplifying Complex Health Economic Model Structure Through Artificial Intelligence
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization (HCRU) Analysis in Newly Diagnosed Mantle Cell Lymphoma: Autologous Stem Cell Transplantation (ASCT) and (HCRU) Alleviation With Adoption of the TRIANGLE Ibrutinib Regimen Without (ASCT)
Sep 9, 2025, 16:22 PM -
Climate Impact of CAR-T Cell Therapy in the Netherlands: A Comparison on the Use Phase Emission Between Standard of Care and CAR-T Cell Therapy in Hemato-oncology
Sep 9, 2025, 16:22 PM -
Societal Impact Analysis of Introducing Elexacaftor Tezacaftor Ivacaftor (ELX TEZ IVA) in the Management of People With Cystic Fibrosis in Germany: A Paid and Unpaid Work Productivity Approach
Sep 9, 2025, 16:22 PM -
A Review of NICE Technology Appraisals in Oncology Including Economic Evaluations With Time-Varying Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Half-Cycle Correction: It’s Time to Let It Go
Sep 9, 2025, 16:22 PM -
Uncertainty About How to Translate JCA Into National HTA Submissions (EU-4 and Poland): A Systematic Comparison From an Industry Perspective
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Costs Among Various Disease States in Adults With Hepatitis Delta Virus in Inpatient and Outpatient Settings in the United States
Sep 9, 2025, 16:22 PM -
The Road Ahead: A Qualitative Study Mapping the Experience of Patients With Chronic Kidney Disease
Sep 9, 2025, 16:22 PM -
PACE in Scotland: Utilizing Machine Learning to Assess the Importance of Patient and Clinician Engagement in HTAs in SMC
Sep 9, 2025, 16:22 PM -
Burden of Transfusion in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Results From a Real-World Study in European Countries
Sep 9, 2025, 16:22 PM
